---
$id: https://graph.org.ai/products/commodity/51111755
$type: Product
source: UNSPSC
code: "51111755"
title: "Nogalamycin"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nogalamycin

**UNSPSC Code**: 51111755
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anthracycline antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L059DCD6IP. European Medicines Agency schedules Nogalamycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09341MIG. Nogalamycin generally arises in the molecular formula C39H49NO16. The term NOGALAMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 no. 12 1967, list 7.) NOGALAMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nogalamycin under HS 29419000 and SITC 54139. As of Q4 2014, NOGALAMYCIN remains the US FDA Preferred Term for this commodity. Nogalamycin bears US NLM identifiers UMLS ID C0028261 and NCI Concept Code C700. SMILES: O1C2(C(O)C(N(C)C)C(O)C1OC1C2CC(O)C2C1C(=O)C1C(C(O)C3C(OC4OC(C(OC)C(OC)(C4OC)C)C)CC(O)(C(C3C1)C(=O)OC)C)C2=O)C.

